Iovance is a California-based biotechnology company that develops autologous T cell-based immunotherapies for the treatment of patients with solid tumours and blood cancers.
Business Model:
Revenue: $2.4M
Employees: 201-500
Address: 999 Skyway Road
City: San Carlos
State: CA
Zip: 94070
Country: US
Iovance is a California-based biotechnology company that develops autologous T cell-based immunotherapies for the treatment of patients with solid tumours and blood cancers.
Contact Phone:
+16502607120
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/13/2010
Ticker Symbol:
IOVA
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2013 | Post-IPO Equity | $23M | 10/2018 | Post-IPO Equity | $252M | 11/2013 | Equity | $23.3M | 6/2020 | Post-IPO Equity | $603.7M | 1/2018 | Post-IPO Equity | $172.5M | 6/2016 | Equity | 4 | $100M |
OrbiMed Broadfin Capital Quogue Capital Frazier Healthcare Partners OrbiMed Broadfin Capital Quogue Capital Frazier Healthcare Partners |
5/2020 | Post-IPO Equity | $603.7M | 2/2015 | Post-IPO Equity | $64M | 10/2018 | Post-IPO Equity | $252.2M |
---|
Announced Date | Name | Price |
---|---|---|
10/2013 | Genesis Biopharma |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|